| Anticoagulants, aspirin and dipyridamole in the secondary prevention of cerebral ischaemia: which is the best for which patient? | |
| | |
MedLine Citation:
|
PMID: 17971645 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In this paper, an overview is given of trials with oral anticoagulants and dipyridamole in the secondary prevention after transient ischaemic attack or minor stroke. In patients with atrial fibrillation, the secondary preventive treatment of first choice is oral anticoagulation with an aimed international normalised ratio between 2.0 and 3.0. In patients without a cardiac source of embolism, a combination therapy of low-dose aspirin and dipyridamole 200 mg twice daily is the treatment of choice. These treatment strategies do however not prevent all recurrent strokes or vascular complications, and research for more effective strategies is warranted. |
| | |
Authors:
|
P H A Halkes; A Algra |
Related Documents
:
|
3401095 - Age-related risks of long-term oral anticoagulant therapy. 12968085 - Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial ... 20556385 - Optease vena cava filter optimal indwelling time and retrievability. 9723825 - A new regimen for starting warfarin therapy in out-patients. 8020175 - Ceftriaxone in prevention of complications after cesarean section and its influence on ... 11476305 - Is titanium so bad? medium-term outcome of cemented titanium stems. |
Publication Detail:
|
Type: Journal Article; Review Date: 2007-11-01 |
Journal Detail:
|
Title: Cerebrovascular diseases (Basel, Switzerland) Volume: 24 Suppl 1 ISSN: 1015-9770 ISO Abbreviation: Cerebrovasc. Dis. Publication Date: 2007 |
Date Detail:
|
Created Date: 2007-10-31 Completed Date: 2008-01-02 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9100851 Medline TA: Cerebrovasc Dis Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 107-11 Citation Subset: IM |
Copyright Information:
|
Copyright 2007 S. Karger AG, Basel. |
Affiliation:
|
Department of Neurology, Rudolf Magnus Institute of Neuroscience, Utrecht, The Netherlands. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Anticoagulants
/
therapeutic use* Aspirin / therapeutic use* Brain Ischemia / prevention & control* Dipyridamole / therapeutic use* Humans Platelet Aggregation Inhibitors / therapeutic use* Stroke / prevention & control |
| Chemical | |
Reg. No./Substance:
|
0/Anticoagulants; 0/Platelet Aggregation Inhibitors; 50-78-2/Aspirin; 58-32-2/Dipyridamole |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Action on vascular risk factors: importance of blood pressure and lipid lowering in stroke secondary...
Next Document: Usefulness of antiplatelet drugs in ischaemic stroke prevention--update on new trials.